Reducing human suffering by detecting cancer earlier with patented technology
BioCurex's RECAF(tm) marker is found in all types of major cancers

AGORACOM News Flash

If you're not following the AGORACOM Blog, you are missing great and informative market posts such as my weekly small-cap market talk with Peter Grandich.

Listen to this week's show that discusses the significance of this week's events on small-cap markets, including sovereign debt, the $USD Index and falling gold prices.

Message: In Publication

080115_sheen
Rank: [?]
Treasurer
Points: [?]
835
Rating: [?]
Votes: 11 Score: 2.7
  • Currently 2.7/5 Stars.
Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

In Publication

posted on Dec 02, 08 09:05AM

Has BioCurex submitted any papers to any peer-reviewed or scientific journal?

Does the company plan on submitting any papers before they enter into any more agreements?

What would be the reason for not publishing data besides waiting for patent protection?

Thank you.



New Message

Please login to post a reply

AGORACOM Quick Tips

Start A New HUB. Control. Quality. Refreshing. ... Start One Now

President's D.D.

New feature: Hub Presidents can add important links here.

Stock Quote